U.S. Markets close in 2 hrs, 43 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,172.38 | 148.96 | 1.49% |
| NASDAQ | 2,144.27 | 31.83 | 1.51% |
| S&P 500 | 1,086.68 | 17.38 | 1.63% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 1.20 09:30 AM EST | |
|---|---|---|
| Day High | 1.2499 09:53 AM EST |
|
| Range | 0.05 |
| Volume | 891,500 | |
|---|---|---|
| 30-Day Avg Vol | 3.30 M |
|
| Difference | -73.03% |
| Market Cap | 155.27 M | |
|---|---|---|
| Mkt Cap Chg | 1.26 M |
| Shares Out | 126.23 M | |
|---|---|---|
| % Shrs Traded | 0.71% | |
| 1yr EPS Est | -0.119 |
| 52-Wk Low | 0.26 | |
|---|---|---|
| 52-Wk High | 4.54 |
|
| Range | 4.28 |
| Prev Close | 1.22 11/6/09 | |
|---|---|---|
| Today's Open | 1.22 | |
| Change | 0.00% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 13.59 M |
| Revenue (LFY) | 265,000 | |
|---|---|---|
| Earnings (LFY) | -12.22 M | |
| Earnings (MRQ) | -3.87 M | |
| Next Earn Est | -0.029 | |
| Next Earnings | 11/09/2009 |
|
| EPS (TTM) | -0.16 | |
| 1yr EPS Growth | 25.62% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -10.00 | |
| PEG Ratio | — | |
| Return on Equity | -74.30 | |
| Beta | 1.02 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Targeting chronic viral diseases and immune disorders, Hemispherx Biopharma hopes to do a world of good with its RNA (ribonucleic acid) and other drugs. The company has acquired the rights to Alferon N, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.029 12:00 AM EST | — — |
—
—
|
| Last Quarter | -0.031 6/30/09 | -0.04 6/30/09 |
-0.009
Missed
|
| 2 Quarters Ago | — 3/31/09 | -0.04 3/31/09 |
—
—
|
| Quarterly - 06/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 17,000.00 | 265,000.00 |
| Gross Profit | -289,000.00 | -533,000.00 |
| Operating Income | -3.98 M | -12.81 M |
| Net Income | -3.87 M | -12.22 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts